References

BD MAX™ MRSA Assay [package insert]. Quebec, Qc, Canada: BD Diagnostics; 2020. Accessed May 28, 2022. https://www.bd.com/resource.aspx?IDX=28026.

Biomerieux. Biofire® Covid-19 test package insert. August 2021. Accessed May 24, 2022. https://www.biofiredefense.com/wp-content/uploads/2021/09/BioFire-COVID-19-v1.1-IFU-DFA2-PRT-0134-04.pdf.

Bonetta L. Prime time for Real-Time PCR. Nature Methods. 2005;2:305-312. Accessed May 25, 2022. https://www.nature.com/nmeth/journal/v2/n4/full/nmeth0405-305.html.

Boughton B. Universal PCR Screening for MRSA may cut costs, reduce infection. September 13, 2009. In Medscape Medical News. Accessed May 25, 2022. https://www.medscape.com/viewarticle/708813.

CDC Response: A Year in Review. 2010. Centers for Disease Control and Prevention Website. Accessed May 25, 2022. https://www.cdc.gov/h1n1flu/yearinreview.htm.

Centers for Disease Control and Prevention. Evaluation of rapid influenza diagnostic tests for detection of Novel Influenza A (H1N1) Virus ---United States, 2009. Morbidity and Mortality Weekly Report. August 7, 2009;58(30):826-829. Accessed May 25, 2022. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5830a2.htm.

Cepheid. Xpert® C. difficile package insert. October 2019. Accessed May 24, 2022. https://www.cepheid.com/Package%20Insert%20Files/Xpert%20C.difficile%20ENGLISH%20Package%20Insert%20300-8023%20Rev.%20G.pdf.

Cepheid. Xpert^® Xpress SARS-CoV-2 package insert. October 2020. Accessed May 24, 2022. https://www.cepheid.com/Package%20Insert%20Files/Xpert%20Xpress%20SARS-CoV-2%20Assay%20ENGLISH%20Package%20Insert%20302-3787%20Rev.%20B.pdf.

Desjardins M, Guibord C, Lalonde B, Toye B, Ramotar K. Evaluation of the IDI-MRSA Assay for the detection of methicillin-resistant Staphylococcus aureus from nasal and rectal specimens pooled in selective broth. J Clin Microbiol. 2006 April;44(4):1219-1223. Accessed May 25, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448652/.

Dhamad AE, Abdal Rhida MA. COVID-19: Molecular and serological detection methods. PeerJ. 2020;8:e10180. Published 2020 Oct 7. doi:10.7717/peerj.10180.

Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol. 2009;47(10):3211-3217. doi:10.1128/JCM.01082-09.

Farley JE, Stamper PD, Ross T, Cai M, Speser S, Carroll KC. Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from an at-risk community population. J Clin Microbiol. 2008;46(2):743-746. doi:10.1128/JCM.02071-07.

Forrest GN, Mehta S, Weeks E, Lincalis DP, Johnson JK, Venezia RA. Impact of rapid in situ hybridization testing on coagulase negative staphylocci positive blood cultures. J Antimicrob Chemother. 2006;58(1):154-158. Accessed May 15, 2022. https://jac.oxfordjournals.org/content/58/1/154.full.

Interim Guidance for Influenza Surveillance: Prioritizing RT-PCR Testing in Laboratories. 2009. Centers for Disease Control and Prevention Website. Accessed May 25, 2022. https://www.cdc.gov/h1n1flu/screening.htm.

Interim Guidance for the Detection of Novel Influenza A Virus Using Rapid Influenza Diagnostic Tests. 2009. Centers for Disease Control and Prevention Website. Accessed May 25, 2022. https://www.cdc.gov/h1n1flu/guidance/rapid_testing.htm.

Leber A, Editor. Clinical Microbiology Procedures Handbook. 4nd ed. Washington, DC: ASM Press; 2016.

Lieberman JA, Pepper G, Naccache SN, Huang ML, Jerome KR, Greninger AL. Comparison of commercially available and laboratory-developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol. 2020;58(8):e00821-20. Published 2020 Jul 23. doi:10.1128/JCM.00821-20.

Persing DH, ed-in-chief.Molecular Microbiology: Diagnostic Principles and Practice. 3rd ed. Washington, DC: ASM Press; 2016.

Pfaller MA. Molecular approaches to diagnosing and managing infectious diseases: practicality and costs. Emerg Infect Dis. 2001;eid0702. Accessed May 25, 2022. https://wwwnc.cdc.gov/eid/article/7/2/70-0312_article.htm.

Rossney AS, Herra CM, Brennan GI, Morgan PM, O'Connell B. Evaluation of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay using the GeneXpert Real-Time PCR platform for rapid detection of MRSA from screening specimens. J Clin Microbiol. 2008;46(10):3285-3290. Accessed May 25, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566096/.

Serajian S, Ahmadpour E, Oliveira SMR, Pereira ML, Heidarzadeh S. CRISPR-Cas Technology: Emerging applications in clinical microbiology and infectious diseases. Pharmaceuticals (Basel). 2021;14(11):1171. Published 2021 Nov 17. doi:10.3390/ph14111171.

Tenover FC, Tickler IA, Le VM, Dewell S, Mendes RE, Goering RV. Updating molecular diagnostics for detecting methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates in blood culture bottles. J Clin Microbiol. 2019;57(11):e01195-19. Published 2019 Oct 23. doi:10.1128/JCM.01195-19.

The 2009 H1N1 Pandemic: Summary Highlights, April 2009-April 2010. 2010. Centers for Disease Control and Prevention Website. Accessed May 25, 2022. https://www.cdc.gov/h1n1flu/cdcresponse.htm.